Tern PLC Company Update Call Transcript
As I say, welcome to the Tern investor webinar, my name is Tim Metcalf, I'm Managing Director of IFC advisory, which is Tern's financial PR and Investor Relations advisors. With me today, Ian Ritchie, Al Sisto, Sarah Payne and Matthew Scherba from Tern and we're very pleased to have Jo Halliday from Talking Medicines. Joe is going to give a presentation on Talking Medicines and some very exciting developments and things that are going on there.
Then I'm going to hand over to Matthew, who's going to go through Konektio, where he has been secunded to recently. And then Ian and AI going to say a few words, a lot of these are reflective of the feedback that we've received from a number of shareholders ahead of this presentation.
And I'd like to start by saying thank you very much for everybody who's shared their opinions and their questions and their points of view. These have all been noted, they have been presented by me to the board and taken into account when putting together today's event. However, we do welcome additional questions, we will attempt
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |